As a subsequence to the DNA damage and alteration during the initiation of CML, phosphorylation of MDM2 protein will occur, which stops the inhibitory effect of MDM2 protein on the p53 gene activation. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.